Characteristics | Missed probes types, N | Number | Proportion | |||
---|---|---|---|---|---|---|
B | D | E | No missed probe | |||
Treatment history | ||||||
New | 1 | 7 | 37 | 5 | 50 | 55.6% |
Relapse | 2 | 25 | 1 | 1 | 29 | 32.2% |
Failure | – | – | 7 | – | 7 | 7.8% |
A loss to follow up | – | 1 | 3 | – | 4 | 4.4% |
Total | 3 | 33 | 48 | 6 | 90 | 100.0% |
Specimen type | ||||||
Sputum | 1 | 4 | 51 | 6 | 62 | 62.0% |
Extrapulmonary | 2 | 6 | 30 | – | 38 | 38.0%) |
Total | 3 | 10 | 81 | 6 | 100 | 100.0% |
Extrapulmonary samples | ||||||
Lymph node | 2 | 2 | 15 | – | 19 | 50.0% |
Pleural fluid | – | 2 | 3 | – | 5 | 13.2% |
Pus | – | – | 4 | – | 4 | 10.5% |
Abscess | – | – | 4 | – | 4 | 10.5% |
Ascetic fluid | – | – | 3 | – | 3 | 8.0% |
Unspecified body fluid | – | 1 | 1 | – | 2 | 5.2% |
BAL | – | 1 | – | – | 1 | 2.6% |
Total | 2 | 6 | 30 | – | 38 | 100.0% |
GeneXpert semi-quantification of MTB | ||||||
Very low | – | – | 11 | 3 | 14 | 14% |
Low | 1 | 3 | 19 | – | 23 | 23% |
Medium | 1 | 5 | 29 | 1 | 36 | 36% |
High | 1 | 2 | 22 | 2 | 27 | 27% |
Total | 3 | 10 | 81 | 6 | 100 | 100% |